Acutus Medical (AFIB) Competitors $0.01 -0.02 (-64.52%) As of 02:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock AFIB vs. QNRX, VERO, NAOV, CTCX, TTOO, TIVC, BBLG, NDRA, HSDT, and AVGRShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Quoin Pharmaceuticals (QNRX), Venus Concept (VERO), NanoVibronix (NAOV), Carmell (CTCX), T2 Biosystems (TTOO), Tivic Health Systems (TIVC), Bone Biologics (BBLG), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), and Avinger (AVGR). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Quoin Pharmaceuticals Venus Concept NanoVibronix Carmell T2 Biosystems Tivic Health Systems Bone Biologics ENDRA Life Sciences Helius Medical Technologies Avinger Quoin Pharmaceuticals (NASDAQ:QNRX) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment, risk and earnings. Does the media refer more to QNRX or AFIB? In the previous week, Quoin Pharmaceuticals had 2 more articles in the media than Acutus Medical. MarketBeat recorded 2 mentions for Quoin Pharmaceuticals and 0 mentions for Acutus Medical. Quoin Pharmaceuticals' average media sentiment score of 0.01 beat Acutus Medical's score of 0.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Quoin Pharmaceuticals Neutral Acutus Medical Neutral Which has preferable valuation & earnings, QNRX or AFIB? Quoin Pharmaceuticals has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuoin PharmaceuticalsN/AN/A-$8.69M-$48.81-0.17Acutus Medical$7.16M0.05-$81.66MN/AN/A Which has more volatility and risk, QNRX or AFIB? Quoin Pharmaceuticals has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.09, suggesting that its stock price is 109% less volatile than the S&P 500. Does the MarketBeat Community favor QNRX or AFIB? Acutus Medical received 7 more outperform votes than Quoin Pharmaceuticals when rated by MarketBeat users. However, 55.56% of users gave Quoin Pharmaceuticals an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote. CompanyUnderperformOutperformQuoin PharmaceuticalsOutperform Votes555.56% Underperform Votes444.44% Acutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% Do institutionals and insiders have more ownership in QNRX or AFIB? 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 3.7% of Quoin Pharmaceuticals shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is QNRX or AFIB more profitable? Quoin Pharmaceuticals has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Quoin Pharmaceuticals' return on equity of -125.60% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Quoin PharmaceuticalsN/A -125.60% -64.77% Acutus Medical -272.74%-311.64%-11.57% SummaryQuoin Pharmaceuticals beats Acutus Medical on 7 of the 12 factors compared between the two stocks. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$328,000.00$4.47B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E RatioN/A29.4326.8419.71Price / Sales0.0567.72391.39116.98Price / CashN/A51.0838.2534.62Price / Book-0.376.236.794.50Net Income-$81.66M$68.16M$3.23B$248.18M7 Day PerformanceN/A18.33%4.07%1.14%1 Month PerformanceN/A23.04%12.52%15.18%1 Year PerformanceN/A20.61%16.83%6.55% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.01-64.5%N/A-47.5%$328,000.00$7.16M0.00340Gap DownHigh Trading VolumeQNRXQuoin Pharmaceuticals0.3415 of 5 stars$6.12-1.1%N/A-68.4%$3.60MN/A-1.514VEROVenus Concept0.8583 of 5 stars$2.49+2.5%N/A-66.5%$3.55M$64.83M-0.31410Earnings ReportGap DownNAOVNanoVibronix0.2841 of 5 stars$4.11-0.2%N/A-83.7%$3.40M$2.56M-3.3420Earnings ReportCTCXCarmellN/A$0.15-1.3%N/A+54.3%$3.20M$32,839.000.0014TTOOT2 BiosystemsN/A$0.15+11.5%$5.00+3,348.3%-97.3%$3.05M$7.68M0.00180Analyst ForecastTIVCTivic Health Systems0.0886 of 5 stars$4.23+7.4%N/A-45.5%$2.59M$780,000.000.0010Earnings ReportBBLGBone Biologics1.2625 of 5 stars$0.73-2.6%N/A-51.6%$2.39MN/A0.002Positive NewsNDRAENDRA Life Sciences1.6682 of 5 stars$3.45+5.8%$50.00+1,349.3%-100.0%$1.94MN/A0.0020HSDTHelius Medical Technologies0.7437 of 5 stars$4.28+1.8%N/A-77.7%$1.75M$434,000.00-0.6930Positive NewsGap UpAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.26M-0.0470Analyst Forecast Related Companies and Tools Related Companies QNRX Competitors VERO Competitors NAOV Competitors CTCX Competitors TTOO Competitors TIVC Competitors BBLG Competitors NDRA Competitors HSDT Competitors AVGR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFIB) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AFIB Stock Free AFIB Stock Alerts